Back to Business

Latigo Biotherapeutics prices $345.6M IPO at $18 per share

Business August 7, 2026 at 12:15 AM

Latigo Biotherapeutics prices $345.6M IPO at $18 per share

Investing.com

Read at Investing.com

More Stories

Exclusive-Alibaba plans to charge big users of its next open-source AI model, sources say

Exclusive-Alibaba plans to charge big users of its next open-source AI model, sources say

🇺🇸 Investing.com 22m ago

Charter Hall Retail FY26 slides: net lease pivot complete, 3.5% growth ahead

Charter Hall Retail FY26 slides: net lease pivot complete, 3.5% growth ahead

🇺🇸 Investing.com 24m ago

Charter Hall Retail REIT FY26 slides: NTA jumps 8.4%, guidance up

Charter Hall Retail REIT FY26 slides: NTA jumps 8.4%, guidance up

🇺🇸 Investing.com 25m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play